A COVID-19 vaccine developed by scientists at Oxford University is safe and has produced an immune response in early-stage clinical trials in healthy volunteers, preliminary results say.
The vaccine, called AZD1222 and under development by AstraZeneca and scientists at Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
More to come.
